Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

NCT04902807 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT04902807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04902807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Observational
Overall status
Completed
Start date
September 7, 2021
Completion date
October 21, 2025
Enrollment
325 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apeced, autoimmune anemia, autoimmune cytopenia, autoimmune diabetes, autoimmune diseases, autoimmune hepatitis, autoimmune lymphoproliferative syndrome, autoimmune rheumatologic disease, autoimmune thrombocytopenia, benta, combined immunodeficiency, ebv lymphoproliferation, enteropathy, autoimmune, hemophagocytic lymphohistiocytoses, ibd, ipex, juvenile idiopathic arthritis, primary immunodeficiency, ras-associated autoimmune leucoproliferative disease, systemic lupus erythematosus